Evidence map›Paper›PMID 26329882›Full record

ArticleScientific reports2015

Fibroblast growth factor 21 in breast milk controls neonatal intestine function.

Aleix Gavaldà-Navarro, Elayne Hondares, Marta Giralt, Teresa Mampel, Roser Iglesias, Francesc Villarroya

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 32 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Corticosterone induces obesity partlyFrontiers in endocrinology · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Aleix Gavaldà-NavarroDepartament de Bioquimica i Biologia Molecular, Institute of Biomedicine (IBUB), University of Barcelona, Av Diagonal 643, 08028 Barcelona, Catalonia, Spain.
Elayne HondaresDepartament de Bioquimica i Biologia Molecular, Institute of Biomedicine (IBUB), University of Barcelona, Av Diagonal 643, 08028 Barcelona, Catalonia, Spain.
Marta GiraltDepartament de Bioquimica i Biologia Molecular, Institute of Biomedicine (IBUB), University of Barcelona, Av Diagonal 643, 08028 Barcelona, Catalonia, Spain.
Teresa MampelDepartament de Bioquimica i Biologia Molecular, Institute of Biomedicine (IBUB), University of Barcelona, Av Diagonal 643, 08028 Barcelona, Catalonia, Spain.
Roser IglesiasDepartament de Bioquimica i Biologia Molecular, Institute of Biomedicine (IBUB), University of Barcelona, Av Diagonal 643, 08028 Barcelona, Catalonia, Spain.
Francesc VillarroyaDepartament de Bioquimica i Biologia Molecular, Institute of Biomedicine (IBUB), University of Barcelona, Av Diagonal 643, 08028 Barcelona, Catalonia, Spain.
Centro de Investigación Biomédica en Red · ESUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

FGF21 is a hormonal factor with important functions in the control of metabolism. FGF21 is found in rodent and human milk. Radiolabeled FGF21 administered to lactating dams accumulates in milk and is transferred to neonatal gut. The small intestine of neonatal (but not adult) mice highly expresses β-Klotho in the luminal area. FGF21-KO pups fed by FGF21-KO dams showed decreased expression and circulating levels of incretins (GIP and GLP-1), reduced gene expression of intestinal lactase and maltase-glucoamylase, and low levels of galactose in plasma, all associated with a mild decrease in body weight. When FGF21-KO pups were nursed by wild-type dams (expressing FGF21 in milk), intestinal peptides and digestive enzymes were up-regulated, lactase enzymatic activity was induced, and galactose levels and body weight were normalized. Neonatal intestine explants were sensitive to FGF21, as evidenced by enhanced ERK1/2 phosphorylation. Oral infusion of FGF21 into neonatal pups induced expression of intestinal hormone factors and digestive enzymes, lactase activity and lactose absorption. These findings reveal a novel role of FGF21 as a hormonal factor contributing to neonatal intestinal function via its presence in maternal milk. Appropriate signaling of FGF21 to neonate is necessary to ensure optimal digestive and endocrine function in developing intestine.

Indexed as

Administration, OralAnimalsAnimals, NewbornBody WeightFemaleFibroblast Growth FactorsGalactoseGene Expression Regulation, DevelopmentalGlucuronidaseHormonesHumansIncretinsIntestinal AbsorptionIntestinal MucosaIntestinesKlotho Proteinsfibroblast growth factor 21Fibroblast Growth FactorsGalactoseGlucuronidaseHormonesIncretinsKlotho ProteinsLactase

Identifiers

PMID26329882
PMCPMC4557064
OpenAlexW2408297146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.